Ignite Creation Date:
2025-12-24 @ 4:50 PM
Ignite Modification Date:
2026-01-17 @ 2:02 PM
Study NCT ID:
NCT05503550
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2025-12-16
First Post:
2022-08-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pre-Approval Access Single Patient Request for Talquetamab in Relapsed or Refractory Multiple Myeloma
Sponsor:
Organization: